3Spine gets FDA exemption for implant trial

Spinal Tech

The FDA gave an investigational device exemption to spine devicemaker 3Spine.

The exemption will allow 3Spine to study its Motus device in a clinical trial, according to a June 22 news release. The company finished contracting and site initiation at 16 U.S. centers for a prospective study.

Motus is an implant used in the BalancedBack total joint replacement procedure. It is designed to address leg pain, back pain and spinal instability, 3Spine said.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers